Literature DB >> 11084288

Proteasome activation by poly-ADP-ribose-polymerase in human myelomonocytic cells after oxidative stress.

O Ullrich1, O Ciftci, R Hass.   

Abstract

Cytotoxic action of a variety of antitumor drugs generate oxidatively modified proteins that are predominantly metabolized via the proteasome. In the present study, a differentiation-retrodifferentiation cell system was exposed to oxidative stress by hydrogen peroxide treatment. Thus, the activity of the nuclear proteasome in proliferating human U937 leukemic cells increased by 2.5-fold after hydrogen peroxide treatment. In contrast, growth-arrested differentiated U937 cells demonstrated 40% less constitutive proteasomal activity, which was not inducible after hydrogen peroxide exposure. After a retrodifferentiation process, however, in which differentiated U937 cells resume autonomous growth again, the proteasomal activity was indistinguishable from that in U937 control cells, both constitutively and after induction of oxidative stress. Moreover, cells of TUR, a differentiation-resistant U937 subclone, expressed an elevated constitutive proteasomal activity that increased by 2.5-fold after oxidative stress. Immunoblot analysis revealed that these differences in proteasomal activities did not correlate with proteasome protein expression but with protein levels of the nuclear enzyme poly-ADP-ribose-polymerase (PARP). Further studies using specific PARP inhibitors revealed that the noninducible proteasome activity in differentiated U937 cells was PARP independent, whereas the increased activity level in oxidatively stressed TUR cells was downregulated upon PARP inhibition. Immunoprecipitation experiments demonstrated a protein-protein interaction of the functional active PARP with the proteasome in correlation with the proteasome activity. Similar results were obtained by analyzing protein carbonyls after oxidative stress. Taken together, these data suggest that proliferating, rather than growth-arrested, cells metabolize oxidatively damaged nuclear proteins via the proteasome by expressing high levels of PARP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11084288     DOI: 10.1016/s0891-5849(00)00399-3

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  8 in total

1.  PARP-1 deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine asthma model.

Authors:  R Datta; A S Naura; M Zerfaoui; Y Errami; M Oumouna; H Kim; J Ju; V P Ronchi; A L Haas; A H Boulares
Journal:  Allergy       Date:  2011-01-28       Impact factor: 13.146

Review 2.  Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme.

Authors:  Pál Pacher; Csaba Szabó
Journal:  Antioxid Redox Signal       Date:  2005 Nov-Dec       Impact factor: 8.401

3.  Involvement of CD11b integrin in the alteration of metabolic factors after phorbol ester stimulation of human myeloid leukemia cells.

Authors:  Katharina Mandel; Anna Otte; Ralf Hass
Journal:  Cell Commun Signal       Date:  2012-07-11       Impact factor: 5.712

Review 4.  The proteasome and the degradation of oxidized proteins: part III-Redox regulation of the proteasomal system.

Authors:  Tobias Jung Annika Höhn; Tilman Grune
Journal:  Redox Biol       Date:  2014-01-14       Impact factor: 11.799

5.  TRPM2 regulates TXNIP-mediated NLRP3 inflammasome activation via interaction with p47 phox under high glucose in human monocytic cells.

Authors:  Hisa Hui Ling Tseng; Chi Teng Vong; Yiu Wa Kwan; Simon Ming-Yuen Lee; Maggie Pui Man Hoi
Journal:  Sci Rep       Date:  2016-10-12       Impact factor: 4.379

6.  A Proteomic Platform Enables to Test for AML Normalization In Vitro.

Authors:  Samuel M Meier-Menches; Benjamin Neuditschko; Lukas Janker; Marlene C Gerner; Klaus G Schmetterer; Albrecht Reichle; Christopher Gerner
Journal:  Front Chem       Date:  2022-02-01       Impact factor: 5.221

7.  Metabolic Dynamics in Short- and Long-Term Microgravity in Human Primary Macrophages.

Authors:  Cora S Thiel; Christian Vahlensieck; Timothy Bradley; Svantje Tauber; Martin Lehmann; Oliver Ullrich
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

8.  Interferon-stimulated gene products as regulators of central carbon metabolism.

Authors:  Kourosh H Ebrahimi; Javier Gilbert-Jaramillo; William S James; James S O McCullagh
Journal:  FEBS J       Date:  2020-12-01       Impact factor: 5.622

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.